Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMAX CORP Delisting Announcement 2011

Feb 10, 2011

31800_dlst_2011-02-10_87d2aecf-098f-4493-8d9e-1e16766e9389.zip

Delisting Announcement

Open in viewer

Opens in your device viewer

PAGEBREAK

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-24216

IMAX Corporation

The Nasdaq Global Select Market

(Exact name of registrant as specified in its charter, and name of Exchange where security is listed and/or registered)

2525 Speakman Drive, Mississauga, Ontario, Canada, L5K 1B1 (905) 403-6500

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

Common Shares, no par value

(Description of Class of Securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
o 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with
its rules to strike the class of securities from listing and/or
withdraw registration on the Exchange. 1
þ Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the
rules of the Exchange and the requirements of 17 CFR 240-12d2-2(c)
governing the voluntary withdrawal of the class of securities from
listing and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934, IMAX Corporation certifies that it has reasonable grounds to believe that it meets all the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

Date: February 10, 2011

By:
Name: Richard L. Gelfond
Title: Chief Executive Officer

1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Folio /Folio